Cardiovascular safety of antidiabetes drugs in doubt

Clinical trials need to assess heart failure riskRelated items from OnMedicaCaution urged over intensive glucose controlNew study underlines rosiglitazone cardiovascular riskExperts query risks of pioglitazoneDrugs regulators “put profits before patients”Daily aspirin use linked to major bleeding
Source: OnMedica Latest News - Category: UK Health Source Type: news